Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

QDEL

QuidelOrtho Corporation

Dec 13 • 11:09AM ET

41.14

Dollar change -0.46
Percentage change -1.09	%

Healthcare • Medical Devices • USA • NASD

Peers: ABT TMO BDX BIO HOLX DGX LH ALC COO RMD

| Held by: IJR VTI VB AVUV VBR VXF IJS SPSM SLYV IHI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-27.89	Insider Own	1.46%	Shs Outstand	67.20M	Perf Week	7.71%
Market Cap	2.77B	Forward P/E	16.75	EPS next Y	2.46	Insider Trans	-92.69%	Shs Float	66.27M	Perf Month	2.81%
Income	-1866.60M	PEG	-	EPS next Q	0.58	Inst Own	96.75%	Short Float	5.90%	Perf Quarter	-10.54%
Sales	2.81B	P/S	0.98	EPS this Y	-56.23%	Inst Trans	-1.90%	Short Ratio	4.67	Perf Half Y	12.88%
Book/sh	47.42	P/B	0.87	EPS next Y	35.86%	ROA	-24.34%	Short Interest	3.91M	Perf Year	-41.69%
Cash/sh	2.14	P/C	19.26	EPS next 5Y	7.20%	ROE	-45.79%	52W Range	29.74 - 75.86	Perf YTD	-44.17%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-33.71%	52W High	-45.76%	Beta	0.10
Dividend TTM	-	Quick Ratio	0.81	Sales past 5Y	59.83%	Gross Margin	40.18%	52W Low	38.37%	ATR (14)	1.79
Dividend Ex-Date	-	Current Ratio	1.38	EPS Y/Y TTM	-13806.63%	Oper. Margin	3.53%	RSI (14)	53.80	Volatility	4.41% 4.56%
Employees	7100	Debt/Eq	0.86	Sales Y/Y TTM	-9.66%	Profit Margin	-66.33%	Recom	2.10	Target Price	51.62
Option/Short	Yes / Yes	LT Debt/Eq	0.74	EPS Q/Q	-55.80%	Payout	-	Rel Volume	0.28	Prev Close	41.60
Sales Surprise	13.23%	EPS Surprise	213.65%	Sales Q/Q	-2.03%	Earnings	Nov 07 AMC	Avg Volume	837.36K	Price	41.14
SMA20	3.92%	SMA50	2.75%	SMA200	-0.06%	Trades		Volume	69,204	Change	-1.09%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-11-24	Upgrade	Citigroup	Neutral → Buy	$44 → $50
Dec-10-24	Initiated	Jefferies	Hold	$43
Sep-19-24	Resumed	UBS	Neutral	$42 → $50
Sep-05-24	Upgrade	Craig Hallum	Hold → Buy	$40 → $57
Mar-04-24	Downgrade	UBS	Neutral → Sell	$70 → $42
Feb-14-24	Downgrade	JP Morgan	Neutral → Underweight	$66 → $37
Dec-11-23	Downgrade	Citigroup	Buy → Neutral	$95 → $72
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$90 → $125
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$125
Oct-14-22	Upgrade	UBS	Sell → Neutral	$86
Sep-19-22	Initiated	Citigroup	Neutral	$90
Jul-20-22	Initiated	UBS	Sell	$86
Jun-17-22	Resumed	JP Morgan	Neutral	$80 → $110
Feb-22-22	Upgrade	Raymond James	Outperform → Strong Buy	$155 → $130
Jan-22-21	Upgrade	Raymond James	Mkt Perform → Outperform	$250
May-12-20	Downgrade	JP Morgan	Neutral → Underweight	$120 → $158
Mar-26-20	Downgrade	Barclays	Overweight → Equal Weight	$90
Oct-23-18	Resumed	Raymond James	Strong Buy	$80
Mar-08-18	Upgrade	Raymond James	Outperform → Strong Buy
Jan-22-18	Reiterated	Barclays	Overweight	$50 → $60

Show Previous Ratings

Dec-10-24 07:00AM	QuidelOrtho Announces Appointment of Two Independent Directors to its Board (Business Wire) -5.01%
Nov-19-24 09:05PM	QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group (Business Wire)
04:54PM	QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group (Business Wire)
Nov-08-24 02:34AM	QuidelOrtho Corp (QDEL) Q3 2024 Earnings Call Highlights: Strategic Initiatives Drive Growth ... (GuruFocus.com) +12.61%
Nov-07-24 04:05PM	QuidelOrtho Reports Third Quarter 2024 Financial Results (Business Wire)
11:25AM	Loading…
Nov-03-24 11:25AM	QuidelOrtho Corporation (QDEL): Among The Oversold NASDAQ Stocks to Invest in Now? (Insider Monkey)
Oct-28-24 07:00AM	QuidelOrtho to Participate in Three Upcoming Investor Conferences (Business Wire)
Oct-17-24 07:00AM	QuidelOrtho to Report Third Quarter 2024 Financial Results (Business Wire)
Oct-09-24 07:00AM	QuidelOrtho Announces New R&D Executive Leader (Business Wire)
Sep-10-24 07:00AM	QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer (Business Wire)
Sep-05-24 05:25PM	Why QuidelOrtho Stock Blasted 10% Higher Today (Motley Fool) +10.26%
Aug-29-24 07:00AM	VITROS Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S. (Business Wire)
Aug-19-24 07:00AM	QuidelOrtho to Participate in Upcoming Investor Conferences (Business Wire)
Aug-13-24 04:55PM	Is Jana Partners Starting an Activist Campaign Against QuidelOrtho Corporation (QDEL)? (Insider Monkey)
Jul-31-24 04:05PM	QuidelOrtho Reports Second Quarter 2024 Financial Results (Business Wire) +6.90%
07:17PM	Loading…
Jul-23-24 07:17PM	Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 (PR Newswire)
Jul-17-24 07:00AM	QuidelOrtho to Report Second Quarter 2024 Financial Results (Business Wire)
Jun-26-24 08:52AM	Should You Sell QuidelOrtho Corporation (QDEL)? (Insider Monkey)
Jun-25-24 06:41AM	What Made The Brown Capital Management Small Company Fund to Sell QuidelOrtho Corporation (QDEL)? (Insider Monkey)
Jun-19-24 08:27AM	QuidelOrtho Corporation (QDEL) is Excited about the New Product Launch (Insider Monkey)
05:13AM	QuidelOrtho (QDEL) Trembled on Disappointing Guidance (Insider Monkey)
Jun-07-24 11:30AM	Why Is QuidelOrtho (QDEL) Down 2.4% Since Last Earnings Report? (Zacks)
Jun-04-24 05:45AM	QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - QDEL (PR Newswire)
May-30-24 06:20AM	Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL (PR Newswire)
May-27-24 04:28AM	QuidelOrtho (QDEL) Fell after Reporting Below Expected Results (Insider Monkey)
May-23-24 07:00AM	QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference (Business Wire)
May-17-24 01:03PM	Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights QDEL (GlobeNewswire)
May-15-24 04:05PM	QuidelOrtho Opens New Distribution Center in Pedricktown, NJ (Business Wire)
May-10-24 01:02PM	QuidelOrtho Corp Reports Mixed Q1 2024 Results Amid Strategic Shifts and Market Challenges (GuruFocus.com)
12:48PM	QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights QDEL (GlobeNewswire)
01:28PM	Loading…
May-09-24 01:28PM	QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall (Zacks)
11:14AM	QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2024 Earnings Call Transcript (Insider Monkey)
04:06AM	QuidelOrtho Corp (QDEL) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-24 08:56PM	QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:25PM	QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates (Zacks)
04:05PM	QuidelOrtho Reports First Quarter 2024 Financial Results (Business Wire)
May-06-24 09:16AM	Unveiling QuidelOrtho (QDEL) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
05:45AM	QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL (PR Newswire)
May-03-24 06:00AM	QuidelOrtho names ex-Abbott exec Brian Blaser as CEO (MedTech Dive)
May-02-24 08:00AM	QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer (Business Wire) +6.40%
May-01-24 10:01AM	Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-30-24 08:15PM	QDEL Investors With Large Losses Should Contact Robbins LLP for Information About Their Rights in Connection With the QuidelOrtho Corporation Lawsuit (Business Wire)
Apr-17-24 07:00AM	QuidelOrtho To Report First Quarter 2024 Financial Results (Business Wire)
Apr-12-24 11:47AM	QuidelOrtho's (QDEL) New Test to Offer Enhanced Opioid Testing (Zacks)
Apr-10-24 07:00AM	QuidelOrtho Adds Fentanyl Test to Its Vitros Systems as a MicroTip Partnership Assay (Business Wire)
Apr-03-24 10:48AM	QuidelOrtho's (QDEL) QuickVue Gets FDA Nod for COVID Testing (Zacks)
06:38AM	QuidelOrtho pulls FDA submission of 4-virus test (MedTech Dive)
Apr-02-24 09:00AM	QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue COVID-19 Test (Business Wire) -10.32%
Mar-14-24 07:23AM	QuidelOrtho to lay off employees after firing CEO (MedTech Dive)
Mar-07-24 10:44AM	QuidelOrtho's (QDEL) New Approval to Aid Pre-eclampsia Diagnosis (Zacks)
Mar-06-24 04:35PM	QuidelOrtho Receives Health Canada Approval for Quidel Triage PLGF Test for Laboratory Use in Canada (Business Wire)
Feb-26-24 04:30PM	QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference (Business Wire)
Feb-21-24 07:30AM	QuidelOrtho Announces Changes in Executive Leadership (Business Wire) +6.20%
05:27AM	QuidelOrtho fires CEO Doug Bryant (MedTech Dive)
Feb-20-24 01:49PM	QuidelOrtho (QDEL) Stock Crashes After Posting YoY Revenue Decline, Analyst Downgrades - Hagens Berman (GlobeNewswire) +11.57%
Feb-14-24 08:34PM	QuidelOrtho (QDEL) Stock Crashes After Posting YoY Revenue Decline, Analyst Downgrades - Hagens Berman (GlobeNewswire) -32.20%
10:05AM	QuidelOrtho (QDEL) Q4 Earnings and Sales Miss, Margins Fall (Zacks)
09:22AM	QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-13-24 07:30PM	QuidelOrtho (QDEL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:30PM	QuidelOrtho (QDEL) Misses Q4 Earnings and Revenue Estimates (Zacks)
04:40PM	QuidelOrtho Corp (QDEL) Reports Mixed Results Amidst Respiratory Revenue Decline (GuruFocus.com)
04:05PM	QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results (Business Wire)
Feb-12-24 09:16AM	Insights Into QuidelOrtho (QDEL) Q4: Wall Street Projections for Key Metrics (Zacks)
Jan-23-24 07:00AM	QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results (Business Wire)
Dec-22-23 07:00AM	QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-23 04:05PM	QuidelOrtho Receives 510(K) Clearance for Savanna Multiplex Molecular Platform and Savanna HSV 1+2/VZV PCR Assay (Business Wire)
Dec-13-23 05:10AM	Why is QuidelOrtho (QDEL) a Good Stock to Invest in? (Insider Monkey) +7.61%
Nov-16-23 05:05PM	QuidelOrtho to Participate in the Evercore ISI Conference (Business Wire)
Nov-01-23 05:56PM	QuidelOrtho Corp (QDEL) Reports Q3 2023 Financial Results: Revenue at $744 Million (GuruFocus.com)
04:05PM	QuidelOrtho Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-17-23 03:43PM	Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square (PR Newswire)
Oct-12-23 07:00AM	QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023 (Business Wire) -6.17%
Sep-21-23 04:05PM	QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA (Business Wire)
07:02AM	Should You Add QuidelOrtho (QDEL) to Your Portfolio? (Insider Monkey)
Aug-28-23 04:05PM	QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire) +6.33%
Aug-08-23 04:30PM	QuidelOrtho Reports Second Quarter 2023 Financial Results (Business Wire) -7.27%
Jul-25-23 04:00PM	QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row (Business Wire)
01:12PM	QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings (Business Wire)
Jul-19-23 08:15AM	The three-year shareholder returns and company earnings persist lower as QuidelOrtho (NASDAQ:QDEL) stock falls a further 3.2% in past week (Simply Wall St.)
Jul-18-23 04:05PM	QuidelOrtho to Report Second Quarter 2023 Financial Results (Business Wire)
Jun-21-23 08:00PM	QDEL: What does Argus have to say about QDEL? (Argus Research)
Jun-12-23 11:20AM	Declining Stock and Decent Financials: Is The Market Wrong About QuidelOrtho Corporation (NASDAQ:QDEL)? (Simply Wall St.)
May-23-23 07:00AM	QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference (Business Wire)
May-04-23 07:50AM	Q1 2023 QuidelOrtho Corp Earnings Call (Thomson Reuters StreetEvents) -6.53%
May-03-23 04:05PM	QuidelOrtho Reports First Quarter 2023 Financial Results (Business Wire)
Apr-26-23 08:00PM	QDEL: Lowering target price to $74.00 (Argus Research)
Apr-13-23 04:05PM	QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023 (Business Wire) +5.01%
Mar-28-23 11:05AM	QuidelOrtho Announces the Formation of the International QuidelOrtho Womens Leadership Network (QWLN) (Business Wire)
07:54AM	QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 36% Below Their Intrinsic Value Estimate (Simply Wall St.)
Mar-23-23 12:19PM	3 Reasons to Retain QuidelOrtho (QDEL) Stock in Your Portfolio (Zacks)
Mar-13-23 01:00PM	QuidelOrtho's (QDEL) Rapid Antigen Test Gets De Novo FDA Approval (Zacks)
Mar-08-23 04:05PM	QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA (Business Wire)
Mar-04-23 09:08AM	17 High Growth Low PE Stocks (Insider Monkey)
08:19AM	13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-02-23 02:01PM	QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference (Business Wire)
Feb-27-23 11:00AM	ImageMover and QuidelOrtho Partner to Simplify Test-to-Treat Process for Pharmacies (PR Newswire)
05:13AM	QuidelOrtho Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Feb-26-23 08:04AM	12 High Growth Healthcare Stocks to Buy (Insider Monkey)
Feb-18-23 07:14AM	QuidelOrtho Corporation Just Missed Revenue By 8.0%: Here's What Analysts Think Will Happen Next (Simply Wall St.)
Feb-16-23 06:18PM	QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2022 Earnings Call Transcript (Insider Monkey) +5.66%

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Robert Bujarski	Former COO	Dec 09 '24	Proposed Sale	40.40	20,000	808,000		Dec 09 05:00 PM
Carlyle Group Inc.	10% Owner	Nov 21 '24	Sale	35.31	8,260,183	291,700,102	0	Nov 21 05:08 PM
Carlyle Group Inc.	10% Owner	Aug 09 '24	Sale	41.53	74,134	3,078,980	8,260,183	Aug 13 04:30 PM
Carlyle Group Inc.	10% Owner	Aug 08 '24	Sale	41.07	106,705	4,382,446	8,334,317	Aug 09 04:15 PM
Carlyle Group Inc.	10% Owner	Aug 07 '24	Sale	39.94	78,180	3,122,840	8,441,022	Aug 09 04:15 PM
Carlyle Group Inc.	10% Owner	Aug 05 '24	Sale	40.37	118,172	4,770,960	8,606,174	Aug 07 04:30 PM
Carlyle Group Inc.	10% Owner	Aug 06 '24	Sale	40.23	86,972	3,499,160	8,519,202	Aug 07 04:30 PM
Carlyle Partners VI Cayman Hol	10% Owner	Aug 06 '24	Proposed Sale	42.01	246,775	10,367,018		Aug 05 08:28 PM
Carlyle Group Inc.	10% Owner	Aug 01 '24	Sale	41.52	234,935	9,753,465	8,893,813	Aug 05 04:30 PM
Carlyle Group Inc.	10% Owner	Aug 02 '24	Sale	42.10	169,467	7,134,818	8,724,346	Aug 05 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 31 '24	Sale	39.11	164,877	6,447,760	9,128,748	Aug 01 05:01 PM
Carlyle Group Inc.	10% Owner	Jul 30 '24	Sale	39.74	150,590	5,985,089	9,293,625	Aug 01 05:01 PM
Carlyle Group Inc.	10% Owner	Jul 29 '24	Sale	38.85	158,090	6,142,230	9,444,215	Jul 30 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 26 '24	Sale	39.05	103,926	4,058,307	9,602,305	Jul 30 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 25 '24	Sale	38.58	406,809	15,696,721	9,706,231	Jul 26 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 24 '24	Sale	38.97	214,732	8,367,685	10,113,040	Jul 26 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 22 '24	Sale	35.31	135,241	4,775,665	10,427,317	Jul 24 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 23 '24	Sale	36.52	99,545	3,635,490	10,327,772	Jul 24 04:30 PM
WIDDER KENNETH J	Director	Jul 19 '24	Option Exercise	27.91	3,333	93,024	28,472	Jul 23 06:43 PM
Carlyle Group Inc.	10% Owner	Jul 18 '24	Sale	34.13	101,870	3,476,615	10,628,194	Jul 22 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 19 '24	Sale	34.12	65,636	2,239,738	10,562,558	Jul 22 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 16 '24	Sale	33.16	94,861	3,145,151	10,799,701	Jul 18 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 17 '24	Sale	34.81	69,637	2,423,818	10,730,064	Jul 18 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 15 '24	Sale	31.70	93,187	2,954,302	10,894,562	Jul 16 08:17 PM
Carlyle Group Inc.	10% Owner	Jul 12 '24	Sale	32.35	57,253	1,852,189	10,987,749	Jul 16 08:17 PM
Carlyle Group Inc.	10% Owner	Jul 11 '24	Sale	31.37	96,578	3,030,060	11,045,002	Jul 12 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 10 '24	Sale	30.09	24,390	733,971	11,141,580	Jul 12 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 08 '24	Sale	30.39	59,973	1,822,715	11,189,751	Jul 10 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 09 '24	Sale	30.07	23,781	715,109	11,165,970	Jul 10 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 03 '24	Sale	30.87	52,724	1,627,441	11,300,463	Jul 08 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 05 '24	Sale	31.15	50,739	1,580,626	11,249,724	Jul 08 04:30 PM
Carlyle Group Inc.	10% Owner	Jul 02 '24	Sale	31.36	86,454	2,711,095	11,353,187	Jul 03 01:15 PM
Carlyle Group Inc.	10% Owner	Jul 01 '24	Sale	32.21	81,110	2,612,556	11,439,641	Jul 03 01:15 PM
Carlyle Group Inc.	10% Owner	Jun 28 '24	Sale	33.05	49,937	1,650,252	11,520,751	Jul 01 04:30 PM
Carlyle Group Inc.	10% Owner	Jun 27 '24	Sale	33.51	46,380	1,554,398	11,570,688	Jul 01 04:30 PM
Carlyle Group Inc.	10% Owner	Jun 26 '24	Sale	33.19	81,482	2,704,541	11,617,068	Jun 27 04:30 PM
Carlyle Group Inc.	10% Owner	Jun 25 '24	Sale	33.01	67,472	2,227,342	11,698,550	Jun 27 04:30 PM
Carlyle Group Inc.	10% Owner	Jun 24 '24	Sale	34.34	73,713	2,531,371	11,766,022	Jun 25 04:56 PM
Carlyle Group Inc.	10% Owner	Jun 21 '24	Sale	35.07	68,580	2,404,799	11,839,735	Jun 25 04:56 PM
Carlyle Group Inc.	10% Owner	Jun 20 '24	Sale	34.89	67,207	2,344,618	11,908,315	Jun 21 04:30 PM
Carlyle Group Inc.	10% Owner	Jun 18 '24	Sale	35.96	48,541	1,745,606	11,975,522	Jun 21 04:30 PM
Carlyle Group Inc.	10% Owner	Jun 14 '24	Sale	36.19	127,981	4,631,842	12,123,705	Jun 18 05:46 PM
Carlyle Group Inc.	10% Owner	Jun 17 '24	Sale	35.99	99,642	3,586,163	12,024,063	Jun 18 05:46 PM
Carlyle Group Inc.	10% Owner	Jun 13 '24	Sale	37.67	144,234	5,433,190	12,251,686	Jun 14 05:02 PM
Carlyle Group Inc.	10% Owner	Jun 12 '24	Sale	40.23	64,263	2,585,270	12,395,920	Jun 14 05:02 PM
BUECHLER KENNETH F	Director	Apr 12 '24	Option Exercise	21.07	9,041	190,494	83,679	Apr 16 06:18 PM
Busky Joseph M	Chief Financial Officer	Feb 23 '24	Buy	46.35	2,150	99,663	2,150	Feb 26 06:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QDEL

QuidelOrtho Corporation

Upgrade your FINVIZ experience